Argentina IVF (in-vitro fertilization) Market Overview, 2029

The infertility treatment market in Argentina has seen huge development and change since the 1980s. The first effective In Vitro Preparation (IVF) system in Argentina happened in 1986, denoting the start of cutting edge infertility medicines in the country. During the 1990s, there was a striking expansion in the accessibility of Infertility medicines, particularly in significant urban communities like Buenos Aires, with headways in conceptive innovation improving achievement rates. The 2000s achieved significant conversations on the legitimate and moral parts of helped regenerative advances, close by an ascent in the quantity of private richness facilities. This period set up for critical administrative changes in the following ten years. In 2013, Argentina passed the milestone Regulation 26.862, the "Helped Generation Regulation," which expected both public and confidential health care coverage to cover infertility medicines. This regulation essentially expanded openness and moderateness, making medicines accessible to a more extensive fragment of the populace. The 2010s additionally saw public mindfulness crusades and the reception of new advancements like hereditary screening of incipient organisms and cryopreservation. The 2020s keep on seeing a developing Infertilitytreatment market driven by expanded request and progressions in conceptive advances. Vital participants incorporate driving richness facilities and focuses like CEGYR (Centro de Estudios en Ginecología y Reproducción), IFER (Instituto de Ginecología y Fertilidad), and Procrearte. These centers offer a scope of helped regenerative innovations (Workmanship) remembering for vitro preparation (IVF), intrauterine insemination (IUI), and egg freezing, alongside complete demonstrative administrations and customized treatment plans. Drug organizations like Merck and Ferring Drugs give fundamental fruitfulness meds, while clinical gadget makers, for example, Cook Clinical stock high level hardware for ripeness techniques. According to the research report, "Italy Infertility Treatment Market Overview, 2029," published by Bonafide Research, the Italy infertility treatment market is anticipated to add to more than USD 270 Million by 2024–29. In Argentina, There is a developing consciousness of Infertility issues, combined with way of life changes and the pattern of deferred being a parent, which adds to a more popularity for Infertilitymedicines. Continuous innovative work endeavors are supposed to present new and viable strategies for treating fruitlessness, for example, foundational microorganism treatment, which could altogether widen the extent of accessible treatments. This authoritative help makes these administrations more available and reasonable contrasted with numerous different nations, where Infertility medicines frequently accompany high personal expenses. Argentina's richness centers are known for their high level clinical offices, outfitted with cutting edge innovation and staffed by exceptionally prepared experts. These centers give medicines that satisfy worldwide guidelines, making Argentina a cutthroat objective for Infertilitytreatment. Furthermore, the expense of therapies in Argentina is by and large lower than in numerous Western nations, which benefits nearby patients as well as draws in clinical vacationers looking for top caliber, practical choices. One of the champion elements of Argentina's Infertility treatment market is its inclusivity. The country's strategies take special care of different family structures, including single guardians and same-sex couples, offering a more comprehensive methodology contrasted with nations with additional prohibitive regulations. This inclusivity widens the patient base and mirrors a dynamic demeanor towards family building. Argentina has laid out areas of strength for a structure for helped multiplication, guaranteeing that medicines are directed securely and mindfully.

The infertility treatment market in Argentina features various types of IVF cycles, with a notable emphasis on fresh non-donor and frozen non-donor IVF cycles. These cycles, which utilize the patient's own eggs and sperm, are popular due to the advanced medical technologies available and the robust healthcare system that supports such treatments. Fresh non-donor IVF cycles involve retrieving, fertilizing, and transferring the eggs within the same cycle, while frozen non-donor IVF cycles involve using previously frozen embryos, which are thawed and transferred in a subsequent cycle. Both methods offer flexibility and can increase overall success rates, making them prevalent choices in Argentina. In comparison, the United States exhibits a diverse IVF market where all four types of cycles—fresh non-donor, frozen non-donor, frozen donor, and fresh donor—are widely used. The demand for donor eggs and sperm is significant, contributing to the extensive use of both fresh and frozen donor cycles. In Europe, the landscape varies significantly; countries like Spain are known for their liberal regulations and high number of donors, making donor cycles particularly common. Conversely, Germany's stricter laws limit the use of donor eggs, highlighting the regulatory diversity across the continent. In Argentina, Conventional in-vitro fertilization is widely accessible due to the supportive regulatory framework established by Law 26.862, which mandates insurance coverage for infertility treatments. This makes IVF more affordable and accessible compared to countries where such treatments can be prohibitively expensive. Argentina's clinics are equipped with advanced technology and skilled professionals, ensuring high standards of care similar to leading international clinics. In-vitro fertilizationwith ICSI is particularly prominent in Argentina, especially for cases involving male infertility. The country's fertility clinics have extensive experience with ICSI, which involves injecting a single sperm directly into an egg. This technique is essential for couples dealing with severe male factor infertility and has been widely adopted due to its success rates. Argentine clinics offer ICSI at a lower cost than many Western countries, making it an attractive option for both local and international patients. The use of donor eggs is another significant aspect of Argentina's infertility treatment market. The country's inclusive policies and ethical guidelines facilitate the use of donor eggs, providing a viable solution for women with diminished ovarian reserve or genetic concerns. Compared to countries with restrictive laws or high costs for donor egg in-vitro fertilization, Argentina offers a more accessible and affordable option, supported by a robust donor database and streamlined legal processes. Argentina also excels in offering other specialized infertility treatments such as preimplantation genetic diagnosis (PGD) and genetic screening. These technologies, which screen embryos for genetic abnormalities before implantation, are available at many Argentine clinics, ensuring that patients have access to the latest advancements in reproductive medicine. In Argentina, Fertility clinics stand as primary providers, offering specialized services tailored to individual needs, including in-vitro fertilization cycles, fertility assessments, and counseling. These clinics play a pivotal role in guiding patients through their fertility journey, providing personalized treatment plans and support throughout the process. Alongside fertility clinics, hospital and surgical centers also contribute significantly to the landscape of infertility treatment in Argentina. Cryobanks constitute another integral part of Argentina's infertility treatment ecosystem, ensuring the safe preservation and management of reproductive material. These facilities store gametes and embryos, providing patients with options for future use in in-vitro fertilization cycles or other assisted reproductive technologies. Cryobanks play a vital role in extending the reproductive lifespan of individuals by offering solutions for preserving fertility, such as egg and sperm freezing, which can be particularly beneficial for those facing medical treatments that may impact their fertility. Research institutes in Argentina contribute to advancements in infertility treatment through scientific research and clinical trials. These institutes drive innovation in reproductive medicine, exploring new techniques, therapies, and technologies aimed at improving pregnancy outcomes and addressing the diverse needs of patients. By conducting studies and collaborating with healthcare providers, research institutes play a crucial role in expanding knowledge and enhancing the efficacy of infertility treatments available in the country. Comparatively, the distribution of end users in Argentina's infertility treatment market shares similarities with other countries, such as the United States and Europe, where fertility clinics, hospital-based services, cryobanks, and research institutes form integral components of the fertility treatment landscape. ?

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • IVF market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By cycle • Fresh Non-donor IVF Cycle • Frozen Non-donor IVF Cycle • Frozen donor IVF Cycle • Fresh donor IVF Cycle

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Conventional IVF • Conventional IVF • IVF with ICSI (Instracytoplasmic Sperm Injection) • IVF With Donor Eggs • other By End user • Fertility Clinics • Hospital & Surgical Centers • Cryobanks • Research institute The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the IVF industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.